Viva Biotech (1873.HK) Announces 2023 Interim Results:Solid Growth in Main Business, Significant Rebound in Profitability
- Written by PR Newswire
Highlights of the Interim Results as of June 30, 2023:
- Revenue reached RMB1,142.2 million, representing a year-on-year increase of approximately 3.0%
- Gross profit amounted to RMB406.0 million, representing a year-on-year increase of approximately 17.7%
- Adjusted Non-IFRS net profit amounted to RMB146.1 million, representing a year-on-year increase of...














